Pharma News

Merck to Acquire Cidara Therapeutics for $9.2 Billion to Bolster Influenza Prevention Pipeline Pharm'Up

Merck to Acquire Cidara Therapeutics for $9.2 Billion to Bolster Influenza Prevention Pipeline

Pharm'Up

Merck (known as MSD outside the U.S. and Canada) and Cidara Therapeutics, Inc., a biotechnology company specializing...

Novartis’s GanLum Achieves 97.4% Cure Rate in Landmark Phase III Malaria Trial Amid Rising Drug Resistance

Pharm'Up

Novartis, in partnership with Medicines for Malaria Venture (MMV), has announced compelling Phase III results for their...

AstraZeneca and Sun Pharma Partner to Broaden Access to Hyperkalaemia Treatment in India

Pharm'Up

AstraZeneca Pharma India Limited and Sun Pharmaceutical Industries Limited have announced a second exclusive brand partnership in...

Utreglutide (GL0034) Shows Potent Weight Loss and Significant Liver-Fat Reduction in Mid-Stage Trials

Pharm'Up

Sun Pharmaceutical Industries Ltd. has announced highly promising clinical results for its novel investigational once-weekly GLP-1 receptor...

Novo Nordisk Partners with Emcure Pharma to Double Access to Semaglutide (Wegovy®) in India Gemini_Generated_Image_fjktkffjktkffjkt

Novo Nordisk Partners with Emcure Pharma to Double Access to Semaglutide (Wegovy®) in India

Pharm'Up

Novo Nordisk India and Emcure Pharma have announced a strategic partnership to significantly expand the availability of...

Landmark VESALIUS-CV Trial: Repatha Becomes First PCSK9 Inhibitor to Slash Primary Heart Event Risk by 25% Gemini_Generated_Image_lxo68elxo68elxo6

Landmark VESALIUS-CV Trial: Repatha Becomes First PCSK9 Inhibitor to Slash Primary Heart Event Risk by 25%

Pharm'Up

Amgen has announced detailed, pivotal results from its Phase 3 VESALIUS-CV clinical trial, proving that Repatha® (evolocumab)...

Zydus Marks Strategic Entry into China with NMPA Approval for Venlafaxine ER Capsules Gemini_Generated_Image_7yxgtg7yxgtg7yxg

Zydus Marks Strategic Entry into China with NMPA Approval for Venlafaxine ER Capsules

Pharm'Up

Zydus Lifesciences Limited has achieved a pivotal regulatory and commercial breakthrough by securing its first-ever approval from...

Breakthrough in Cardiac Care Personalized Vitamin D3 Treatment Halves Recurrent Heart Attack Risk Gemini_Generated_Image_ftt9u5ftt9u5ftt9

Breakthrough in Cardiac Care Personalized Vitamin D3 Treatment Halves Recurrent Heart Attack Risk

Pharm'Up

A groundbreaking study conducted by heart researchers at Intermountain Health has revealed that a personalized, “target to...

Advocating for Home-Based Kidney Care A Roadmap for Scaling Peritoneal Dialysis (PD) in India Gemini_Generated_Image_teyb94teyb94teyb

Advocating for Home-Based Kidney Care A Roadmap for Scaling Peritoneal Dialysis (PD) in India

Pharm'Up

A new Advocacy Paper, developed by leading nephrology experts, outlines a strategic roadmap to overcome the barriers...

Sandoz Strengthens Oncology Portfolio with Global License for Pertuzumab Biosimilar Gemini_Generated_Image_tn66lqtn66lqtn66

Sandoz Strengthens Oncology Portfolio with Global License for Pertuzumab Biosimilar

Pharm'Up

Sandoz, the global leader in affordable medicines, has announced a significant expansion of its oncology pipeline by...

Merck to Acquire Cidara Therapeutics for $9.2 Billion to Bolster Influenza Prevention Pipeline

Novartis’s GanLum Achieves 97.4% Cure Rate in Landmark Phase III Malaria Trial Amid Rising Drug Resistance

AstraZeneca and Sun Pharma Partner to Broaden Access to Hyperkalaemia Treatment in India

Utreglutide (GL0034) Shows Potent Weight Loss and Significant Liver-Fat Reduction in Mid-Stage Trials

Novo Nordisk Partners with Emcure Pharma to Double Access to Semaglutide (Wegovy®) in India

Landmark VESALIUS-CV Trial: Repatha Becomes First PCSK9 Inhibitor to Slash Primary Heart Event Risk by 25%

Zydus Marks Strategic Entry into China with NMPA Approval for Venlafaxine ER Capsules

Breakthrough in Cardiac Care Personalized Vitamin D3 Treatment Halves Recurrent Heart Attack Risk

Advocating for Home-Based Kidney Care A Roadmap for Scaling Peritoneal Dialysis (PD) in India

Sandoz Strengthens Oncology Portfolio with Global License for Pertuzumab Biosimilar

Read These Too

Navigating Balance Disorders: Causes, Symptoms, and Management

Understanding Seasonal Allergic Rhinitis: Causes, Symptoms, and Relief

Pharmacovigilance Specialist Opportunity at Bausch + Lomb

Career Opportunity: Formulation & Development (Injectable) at Derren Healthcare